Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq
Insider Sale
+$364
-0.08%
Shares
Shares Volume: 54 Shares
Average Share Price: $6.74
INSIDER
Cline Christopher R.
CHIEF FINANCIAL OFFICER (Officer)
reported on Apr 12 2024
traded on Apr 11 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 70,849 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $9,324.86 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 24 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $28,845.41 |
| COMPANY PREVIOUS TRADES |